LncRNA UCA1 in anti-cancer drug resistance

被引:134
|
作者
Wang, Haohao [1 ,2 ]
Guan, Zhonghai [1 ]
He, Kuifeng [1 ,2 ]
Qian, Jiong [1 ]
Cao, Jiang [3 ]
Teng, Lisong [1 ,2 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Ctr Canc, Hangzhou, Zhejiang, Peoples R China
[2] Key Lab Precis Diag & Treatment Hepatobiliary & P, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 2, Coll Med, Clin Res Ctr, Hangzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
long non-coding RNA; UCA1; chemoresistance; cancer; LONG NONCODING RNA; CARCINOMA-ASSOCIATED; CHRONIC MYELOID-LEUKEMIA; CELL LUNG-CANCER; ENHANCES TAMOXIFEN RESISTANCE; TYROSINE KINASE INHIBITORS; BREAST-CANCER; MULTIDRUG-RESISTANCE; POOR-PROGNOSIS; MOLECULAR-MECHANISMS;
D O I
10.18632/oncotarget.18344
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The pivotal role of the long non-coding RNA (lncRNA) urothelial carcinoma associated 1 (UCA1) in anti-cancer drug resistance has been confirmed in many cancers. Overexpression of lncRNA UCA1 correlates with resistance to chemotherapeutics such as cisplatin, gemcitabine, 5-FU, tamoxifen, imatinib and EGFR-TKIs, whereas lncRNA UCA1 knockdown restores drug sensitivity. These studies highlight the potential of lncRNA UCA1 as a diagnostic and prognostic biomarker, and a therapeutic target in malignant tumors. In this review, we address the role of lncRNA UCA1 in anti-cancer drug resistance and discuss its potential in future clinical applications.
引用
收藏
页码:64638 / 64650
页数:13
相关论文
共 50 条
  • [31] Signaling pathways modulated by lncRNA UCA1 during anchorage-independent growth in colorectal cancer
    Leslie, Sophia
    Doxtater, Kyle D.
    Lopez, Samantha
    Ezell, Kristopher
    Anilkumar, Adithya
    Sanchez, Amayrani
    Hafeez, Bilal
    Oraby, Tamer
    Jaggi, Meena
    Loy, Timothy
    Chauhan, Subhash
    Tripathi, Manish K.
    CANCER RESEARCH, 2023, 83 (07)
  • [32] lncRNA GAS8-AS1 downregulates lncRNA UCA1 to inhibit osteosarcoma cell migration and invasion
    Zhuqing Zha
    Qingmin Han
    Wenjing Liu
    Shaochuan Huo
    Journal of Orthopaedic Surgery and Research, 15
  • [33] LncRNA UCA1 Induces Acquired Resistance to Gefitinib by Epigenetically Silencing CDKN1A Expression in Non-small-Cell Lung Cancer
    Xu, Tianwei
    Yan, Shuai
    Wang, Mengwei
    Jiang, Lihua
    Ma, Pei
    Lu, Binbin
    Chen, Qinnan
    Wei, Chenchen
    Wang, Zhaoxia
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [34] Overexpression of lncRNA UCA1 promotes osteosarcoma progression and correlates with poor prognosis
    Li, Wei
    Xie, Peng
    Ruan, Wen-hui
    JOURNAL OF BONE ONCOLOGY, 2016, 5 (02) : 80 - 85
  • [35] Correction to: The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs
    Chao-Jie Wang
    Chun-Chao Zhu
    Jia Xu
    Ming Wang
    Wen-Yi Zhao
    Qiang Liu
    Gang Zhao
    Zi-Zhen Zhang
    Molecular Cancer, 18
  • [36] LncRNA UCA1 Induces Acquired Resistance to Gefitinib by Epigenetically Silencing CDKN1A Expression in non-small-cell lung cancer
    Wang, Z.
    Xu, T.
    Yan, S.
    Jiang, L.
    Wang, M.
    Chen, Q.
    Wei, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S554 - S555
  • [37] SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma
    Cui, Xiaoteng
    Zhao, Chunyan
    Yao, Xuyang
    Qian, Baoxin
    Su, Chao
    Ren, Yuanyuan
    Yao, Zhi
    Gao, Xingjie
    Yang, Jie
    RNA BIOLOGY, 2018, 15 (10) : 1364 - 1375
  • [38] LncRNA WT1-AS downregulates lncRNA UCA1 to suppress non-small cell lung cancer and predicts poor survival
    Wan, Yanhui
    Yao, Da
    Fang, Fuyuan
    Wang, Youyu
    Wu, Guodong
    Qian, Youhui
    BMC CANCER, 2021, 21 (01)
  • [39] lncRNA GAS8-AS1 downregulates lncRNA UCA1 to inhibit osteosarcoma cell migration and invasion
    Zha, Zhuqing
    Han, Qingmin
    Liu, Wenjing
    Huo, Shaochuan
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2020, 15 (01)
  • [40] LncRNA WT1-AS downregulates lncRNA UCA1 to suppress non-small cell lung cancer and predicts poor survival
    Yanhui Wan
    Da Yao
    Fuyuan Fang
    Youyu Wang
    Guodong Wu
    Youhui Qian
    BMC Cancer, 21